American Society for Microbiology, Journal of Virology, 9(96), 2022
DOI: 10.1128/jvi.00332-22
Full text: Download
As improved influenza virus vaccines are being developed, the influenza virus neuraminidase (NA) is becoming an important new target for immune responses. By identifying novel epitopes of anti-NA antibodies, we can improve vaccine design. Additionally, characterizing escape mutations in these epitopes aids in identifying NA antigenic drift in circulating viruses.